Stockscreener 앱 받기
4.58
6.76%
0.29
시장 영업 전:
4.57
-0.010
-0.22%
Helus Pharma Inc 주식(HELP)의 최신 뉴스
symbol__ Stock Quote Price and Forecast - CNN
Helus Pharma (Nasdaq: CYBN) to speak at H.C. Wainwright Neuro Perspectives - Stock Titan
Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference - Investing News Network
Helus Pharma medical chief in June 15 neuro conference chat - Stock Titan
Helus Pharma: Trump-Dekret beschleunigt HLP003 - Börse Global
HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism - Stocktwits
HELP Stock Crashes On Anxiety Trial Results, But Here’s Why Jefferies Sees Up To 200% Upside - Stocktwits
Helus Pharma reports encouraging Phase 2 results for HLP004 anxiety treatment - MSN
Helus Pharma Showcases Mental Health Pipeline at Jefferies Global Healthcare Conference - TipRanks
Cybin (CYBN) showcases Helus Pharma at Jefferies Global Healthcare Conference - Stock Titan
Helus Pharma to Present at Jefferies Global Healthcare Conference Amid Late-Stage Trials for Depression and Anxiety - citybuzz -
Helus Pharma's CEO to speak at Jefferies Global Healthcare Conference on June 4 - Pluang
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York - The Manila Times
Cybin Shares Up Slightly as HELP Backers Focus on Main Trial - Bez Kabli
Helus Pharma (HELP) Stock Analysis Report | Financials & Insights - Benzinga
HELP Should I Buy - Intellectia AI
Helus Pharma Names Michael Cola As CEO For Next Phase Of Growth - Bernama
Helus Pharma CEO Michael Cola steps down; Eric So takes interim CEO role - MSN
Helus Pharma propels therapeutic innovation in mental health and commences trading on Nasdaq - MSN
Helus Pharma Partners With TARA Mind to Boost Phase 3 Depression Trial in Veterans After U.S. Executive Order - TipRanks
Helus Pharma (Nasdaq: HELP) partners with TARA Mind to boost veteran trial access - Stock Titan
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Jefferies reiterates Helus Pharma stock rating on anxiety data - Investing.com
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - The Manila Times
Cybin Inc. will Change its Name to Helus Pharma - marketscreener.com
Helus turns to TARA Mind to reach veterans for depression trial - Stock Titan
Helus Pharma CEO to Spotlight Mental Health Innovation at 29th Milken Global Conference - TipRanks
Helus Pharma (CYBN) interim CEO to join Milken Global Conference health innovation panel - Stock Titan
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - The Manila Times
A Milken health-innovation panel will feature Helus Pharma's interim CEO - Stock Titan
Helus Pharma Partners With TARA Mind to Boost Phase 3 Trial Recruitment for Major Depressive Disorder in Veterans - citybuzz -
Helus Pharma Aligns With U.S. Veteran Mental Health Push in New TARA Mind Partnership - TipRanks
Cybin (CYBN) Helus Pharma joins TARA Mind to boost HLP003 Phase 3 veteran trial - Stock Titan
Helus Pharma partners with TARA Mind for trial recruitment By Investing.com - Investing.com South Africa
Helus Pharma partners with TARA Mind for trial recruitment - Investing.com
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - ChartMill
HELP | Cybin Inc. Common Stock Insider Trading - Quiver Quantitative
Does Robert Langer’s Arrival Reframe Confidence in Cybin’s (HELP) Clinical Strategy and Execution Risk? - Yahoo Finance
2.60%
0.94%
자본화:
|
볼륨(24시간):